/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749709277&Signature=J-PeVNneCh5Hp7vr36awM4MFj43TUbL5OIcut~cOgJJhXoeGGO5VcukaFwHMzB0bBoEEcHuIYN2-q7udN4NeWxno0e1mY8uakUUrCkZupCxjFryuJ3iSgyIshEPLy3y5ykjfBD~OVtTr72noAPVhZawkEO5VTFSXQTFDoavXd0tMl~uMOMskbSt4gnDI9raVVyMqEuFGMe44Kh6cwiHW8bP~bP1MXBTJ45TBjdZrzn~5lrgYtfBIwTM5Y5Rl2AmGm3FuZomT9RqII66ScIbraXSIVM3KAjzaoYpWfZ8vjMfMHHlgJCN5Qgzwa6-QB8V2e9EqeTBYCRp6t-rVH6OW8g__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
CHOSA Oncology AB | Sweden | CHOSA | |
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
|
Curasight A/S | Denmark | CURAS | |
|
Curevac | Germany | CVAC |